If you are looking to invest in Optiscan Imaging Limited’s (ASX:OIL), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your ...

Viewing insider transactions for Optiscan Imaging Limited's (ASX:OIL ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Optiscan’s confocal laser endomicroscopy promises to revolutionise cancer surgery so that it’s done right first time, every time But one important discipline remains stuck in the 19th century: the ...

June 24, 2008 In order to view cells at a high enough magnification to identify cancerous and pre-cancerous growths, doctors currently have to perform biopsy surgery - the invasive removal of cells so ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Optiscan enters exclusive five-year collaboration deal with US-based drug company Long Grove ...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Optiscan Imaging (ASX:OIL) stock is up 157% in the last year, providing strong gains for shareholders. But ...

Optiscan has revealed a novel microscopic imaging device designed specifically for the veterinary medicine market segment. Special Report: Optiscan has revealed a novel microscopic imaging device ...

A look at the shareholders of Optiscan Imaging Limited (ASX:OIL) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to see ...

Since earning FDA clearance for its automated glucose monitoring system in 2017, OptiScan has introduced the device to select hospitals in the U.S. and Europe. Now, the company has raised $20 million ...